Yahoo
NasdaqGM - Delayed Quote USD

Actuate Therapeutics, Inc. Common stock (ACTU)

0.3351 -0.0359 (-9.68%)
At close: October 30 at 4:00:01 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
20,773.3950
22,495.3120
25,160.7340
24,973.8290
20,206.8070
Operating Income
-20,773.3950
-22,495.3120
-25,160.7340
-24,973.8290
-20,206.8070
Net Non Operating Interest Income Expense
319.5880
267.4600
203.5760
309.0310
10.8270
Other Income Expense
--
--
-2,328.1700
-79.8220
36.5790
Pretax Income
-20,453.8070
-22,227.8520
-27,285.3280
-24,744.6200
-20,159.4010
Net Income Common Stockholders
-20,453.8070
-22,227.8520
-27,285.3280
-24,744.6200
-20,159.4010
Diluted NI Available to Com Stockholders
-20,453.8070
-22,227.8520
-27,285.3280
-24,744.6200
-20,159.4010
Basic EPS
-0.87
-1.06
-3.26
-1.29
-1.34
Diluted EPS
-0.87
-1.06
-3.26
-1.29
-1.34
Basic Average Shares
23,088.2440
21,021.8170
8,372.7410
19,111.6360
15,033.7310
Diluted Average Shares
23,088.2440
21,021.8170
8,372.7410
19,111.6360
15,033.7310
Total Operating Income as Reported
-20,773.3950
-22,495.3120
-25,160.7340
-24,973.8290
-20,206.8070
Total Expenses
20,773.3950
22,495.3120
25,160.7340
24,973.8290
20,206.8070
Net Income from Continuing & Discontinued Operation
-20,453.8070
-22,227.8520
-27,285.3280
-24,744.6200
-20,159.4010
Normalized Income
-20,453.8070
-22,227.8520
-27,549.6650
-24,664.7980
-20,195.9800
Interest Income
339.8380
287.7100
222.2930
352.6720
27.0270
Interest Expense
20.2500
20.2500
18.7170
43.6410
16.2000
Net Interest Income
319.5880
267.4600
203.5760
309.0310
10.8270
EBIT
-20,433.5570
-22,207.6020
-27,266.6110
-24,700.9790
-20,143.2010
EBITDA
-20,433.5570
-22,207.6020
-27,266.6110
-24,700.9790
-20,143.2010
Net Income from Continuing Operation Net Minority Interest
-20,453.8070
-22,227.8520
-27,285.3280
-24,744.6200
-20,159.4010
Total Unusual Items Excluding Goodwill
--
--
264.3370
-79.8220
36.5790
Total Unusual Items
--
--
264.3370
-79.8220
36.5790
Normalized EBITDA
-20,433.5570
-22,207.6020
-27,530.9480
-24,621.1570
-20,179.7800
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 8/13/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: